Big Move For Eton Pharmaceuticals, Inc.
Fri, Aug 14, 2026 at 07:34 PM
Eton Pharmaceuticals, Inc. (ETON:NASDAQ) jumped higher at $58.86, representing a gain of 44.3%. On Fri, Aug 14, 2026, ETON:NASDAQ hit a New 2-Week High of $58.86. The stock appeared on our News Catalysts scanner on Fri, Aug 14, 2026 at 12:02 PM in the 'BIOTECH' category. From Fri, Jul 31, 2026, the stock recorded 40.00% Up Days and 18.18% Green Days
About Eton Pharmaceuticals, Inc. (ETON:NASDAQ)
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products utilizing the FDA's 505(b)(2) regulatory pathway, to fulfill an unmet patient need. It has a diversified pipeline of around eight product candidates in various stages of development.
Top 10 Gainers:
- Webus International Limited (WETO:NASDAQ), 127.7%
- MDxHealth SA (MDXH:NASDAQ), 74.89%
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 57.96%
- CBL International Limited (BANL:NASDAQ), 55.92%
- Harte Hanks, Inc. (HHS:NASDAQ), 53.02%
- Movella Holdings Inc. (MVLA:NASDAQ), 50%
- VisionWave Holdings Inc. (VWAV:NASDAQ), 44.72%
- Eton Pharmaceuticals, Inc. (ETON:NASDAQ), 44.26%
- Digital Asset Acquisition Corp. (DAAQ:NASDAQ), 43.53%
- System1, Inc. (SST:NYSE), 38.24%